Insider · CIK 0002005531
Title 19 Promis
Files at PMN (ProMIS Neurosciences Inc.). First filing -, latest -.
In brief
Title 19 Promis files SEC Form 4 as 10% owner at PMN (ProMIS Neurosciences Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Title 19 Promis has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 10 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 25, 2025 | PMN ProMIS Neurosciences Inc. | XIn-the-money exercise Tranche A Common Share Purchase Warrantsderivative | -119,800 | $0.00 | $0 | 345,316 | Aug 14, 2025 |
| Jul 25, 2025 | PMN ProMIS Neurosciences Inc. | XIn-the-money exercise Tranche B Common Share Purchase Warrantsderivative | -119,800 | $0.00 | $0 | 345,316 | Aug 14, 2025 |
| Jul 25, 2025 | PMN ProMIS Neurosciences Inc. | XIn-the-money exercise Tranche C Common Share Purchase Warrantsderivative | -119,800 | $0.00 | $0 | 345,316 | Aug 14, 2025 |
| Jul 25, 2025 | PMN ProMIS Neurosciences Inc. | XIn-the-money exercise Common Shares, no par value | +119,800 | - | - | 2,195,429 | Jul 29, 2025 |
| Jul 25, 2025 | PMN ProMIS Neurosciences Inc. | XIn-the-money exercise Common Shares, no par value | +119,800 | - | - | 2,315,229 | Jul 29, 2025 |
| Jul 25, 2025 | PMN ProMIS Neurosciences Inc. | XIn-the-money exercise Common Shares, no par value | +119,800 | - | - | 2,435,029 | Jul 29, 2025 |
| Jul 25, 2025 | PMN ProMIS Neurosciences Inc. | XIn-the-money exercise Tranche A Common Share Purchase Warrantsderivative | -119,800 | $0.00 | $0 | 345,316 | Jul 29, 2025 |
| Jul 25, 2025 | PMN ProMIS Neurosciences Inc. | XIn-the-money exercise Tranche B Common Share Purchase Warrantsderivative | -119,800 | $0.00 | $0 | 345,316 | Jul 29, 2025 |
| Jul 25, 2025 | PMN ProMIS Neurosciences Inc. | XIn-the-money exercise Tranche C Common Share Purchase Warrantsderivative | -119,800 | $0.00 | $0 | 345,316 | Jul 29, 2025 |
| Jul 29, 2025 | PMN ProMIS Neurosciences Inc. | POpen-market purchase Warrants to Purchase Common Sharesderivative | +539,100 | - | - | 539,100 | Jul 29, 2025 |
Questions about Title 19 Promis
Answered from the filings on this page, as of the latest one.
Is Title 19 Promis buying or selling?
Title 19 Promis has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Title 19 Promis's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Title 19 Promis has 0.
Where does Title 19 Promis file Form 4?
Title 19 Promis has filed Form 4 at PMN (ProMIS Neurosciences Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.